{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:19:03Z","timestamp":1790738343821,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005622","name":"Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijantimicag.2019.06.018","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T12:09:49Z","timestamp":1561550989000},"page":"356-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection"],"prefix":"10.1016","volume":"54","author":[{"given":"Mar\u00eda \u00c1ngeles","family":"Mel\u00e9ndez-Carmona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mu\u00f1oz-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Viedma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Lora-Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0001","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijmm.2014.03.003","article-title":"Phenotypic and genotypic characterisation of Staphylococcus aureus causing musculoskeletal infections","volume":"304","author":"Post","year":"2014","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0002","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0003","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1086\/507633","article-title":"Staphylococcus aureus small colony variants in prosthetic joint infection","volume":"43","author":"Sendi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0004","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jac\/dkp326","article-title":"Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus","volume":"64","author":"Murillo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0005","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0006","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/AAC.04359-14","article-title":"Antimicrobial activity against intraosteoblastic Staphylococcus aureus","volume":"59","author":"Valour","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eimc.2016.08.012","article-title":"Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)","volume":"35","author":"Ariza","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0008","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0009","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1128\/AAC.01163-08","article-title":"Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus","volume":"53","author":"Muller-Serieys","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. C1","key":"10.1016\/j.ijantimicag.2019.06.018_bib0010","first-page":"65","article-title":"Caracterizaci\u00f3n microbiol\u00f3gica, fenot\u00edpica y genot\u00edpica, de la infecci\u00f3n prot\u00e9sica articular por Staphylococcus aureus: Estudio multic\u00e9ntrico en la Comunidad de Madrid","volume":"36","author":"Mu\u00f1oz-Gallego","year":"2018","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0011","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/AAC.50.3.841-851.2006","article-title":"Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages","volume":"50","author":"Barcia-Macay","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0012","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. C","key":"10.1016\/j.ijantimicag.2019.06.018_bib0013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/13.suppl_C.23","article-title":"Rifampicin in the treatment of osteoarticular infections due to staphylococci","volume":"13","author":"Cluzel","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0014","first-page":"218","article-title":"Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives","volume":"9","author":"Van Bambeke","year":"2006","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jac\/dkh110","article-title":"Diffusion of levofloxacin into bone and synovial tissues","volume":"53","author":"Rimmel\u00e9","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0016","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmi.2016.10.002","article-title":"The use of rifampin in staphylococcal orthopaedic-device-related infections","volume":"23","author":"Sendi","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0017","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1093\/jac\/dky318","article-title":"Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization","volume":"73","author":"Rigaill","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0018","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/jac\/dkl079","article-title":"Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model.J","volume":"57","author":"Nguyen","year":"2006","journal-title":"Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0019","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/jac\/dkv371","article-title":"Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis","volume":"71","author":"Tuchscherr","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/AAC.29.4.611","article-title":"Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus","volume":"29","author":"Hackbarth","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0021","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/AAC.00458-08","article-title":"Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection","volume":"52","author":"Murillo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.018_bib0022","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/cid\/ciy600","article-title":"Delafloxacin: a new anti-methicillin-resistant Staphylococcus aureus fluorquinolone","volume":"68","author":"Saravolatz","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:32:55Z","timestamp":1760376775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919301712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0924857919301712"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.06.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}